Adelakun OE, Ade-Omowaye BI, Adeyemi IA, et al
The GLP-1 Megatrend (1 of 4): The Mechanistic Blind Spot No One Wants to Admit Published in Biomedical Research India Ambler and 2 others The rapid ascent of GLP-1based therapies has created one of the most consequential shifts in modern medicine, reshaping clinical practice across obesity, diabetes, cardiometabolic disease, liver pathology, and even neurodegeneration
published by the Journal of the National Cancer Institute in 2002 and 2003 from International Endogenous Hormones and Breast Cancer Collaborative Group data
If you accidentally used a U-40 syringe for tirzepatide, drawing to the "40 unit" mark would pull 1.0 mL instead of 0.4 mL, giving you 2.5 times the intended dose
7 ChengW.NdokaE.HutchC.RoelofsK.MacKinnonA.KhouryB.et al (2020)